{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:28:04Z","timestamp":1793968084409,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Palack\u00fd University Olomouc","doi-asserted-by":"publisher","award":["IGA_PrF_2025_014"],"award-info":[{"award-number":["IGA_PrF_2025_014"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007059","name":"Palack\u00fd University Olomouc","doi-asserted-by":"publisher","award":["IGA_PrF_2026_015"],"award-info":[{"award-number":["IGA_PrF_2026_015"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["25-16634S"],"award-info":[{"award-number":["25-16634S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["00179906"],"award-info":[{"award-number":["00179906"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119382","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:06:36Z","timestamp":1790694396000},"page":"119382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Exploring the structural requirements of fluorinated benzylidene-thiazolidinediones for selective antitrypanosomal activity"],"prefix":"10.1016","volume":"321","author":[{"given":"Michal","family":"Kola\u0159\u00edk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Santar\u00e9m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-6087","authenticated-orcid":false,"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-2622","authenticated-orcid":false,"given":"Joana","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendula","family":"Rydlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Kor\u00e1be\u010dn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-073X","authenticated-orcid":false,"given":"Lucie","family":"Brul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10110","key":"10.1016\/j.ejmech.2026.119382_bib1","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119382_bib2","series-title":"Manson's Tropical Diseases","first-page":"623","article-title":"Human African trypanosomiasis","author":"Burri","year":"2023"},{"key":"10.1016\/j.ejmech.2026.119382_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pathmechdis-031621-025153","article-title":"The pathogenesis of African trypanosomiasis","volume":"18","author":"Pays","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejmech.2026.119382_bib4","unstructured":"Https:\/\/Www.Afro.Who.Int\/Health-Topics\/Human-African-Trypanosomiasis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119382_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/acsinfecdis.4c00472","article-title":"Discovery and development of an advanced lead for the treatment of African trypanosomiasis","volume":"11","author":"Ilbeigi","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119382_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2016.00115","article-title":"The cyclical development of Trypanosoma Vivax in the Tsetse fly involves an asymmetric division","volume":"6","author":"Ooi","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119382_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13071-021-04584-x","article-title":"Global distribution, host range and prevalence of Trypanosoma Vivax: a systematic review and meta-analysis","volume":"14","author":"Fetene","year":"2021","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2026.119382_bib8","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness). Https:\/\/Www.Who.Int\/News-Room\/Fact-Sheets\/Detail\/Trypanosomiasis-Human-African-(Sleeping-Sickness). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119382_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3201\/eid3001.231319","article-title":"Reemergence of human African trypanosomiasis caused by Trypanosoma Brucei rhodesiense, Ethiopia","volume":"30","author":"Abera","year":"2024","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119382_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40475-023-00304-w","article-title":"Human African trypanosomiasis (sleeping Sickness)-Epidemiology, clinical manifestations, diagnosis, treatment, and prevention","volume":"10","author":"Ortiz-Mart\u00ednez","year":"2023","journal-title":"Curr. Trop. Med. Rep."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119382_bib11","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1473-3099(24)00581-4","article-title":"New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine","volume":"25","author":"Lindner","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119382_bib12","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/j.ijid.2011.03.018","article-title":"Human African trypanosomiasis: a review of non-endemic cases in the past 20 years","volume":"15","author":"Migchelsen","year":"2011","journal-title":"Int. J. Infect. Dis."},{"issue":"7 July","key":"10.1016\/j.ejmech.2026.119382_bib13","article-title":"Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad","volume":"17","author":"Antillon","year":"2023","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"10116","key":"10.1016\/j.ejmech.2026.119382_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma Brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"Mesu","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ejmech.2026.119382_bib15","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119382_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed5010029","article-title":"New drugs for human African trypanosomiasis: a twenty first century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"issue":"19","key":"10.1016\/j.ejmech.2026.119382_bib17","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.3390\/molecules27196763","article-title":"Thiazolidin-2,4-Dione scaffold: an insight into recent advances as antimicrobial, antioxidant, and hypoglycemic agents","volume":"27","author":"Kumar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119382_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118363","article-title":"Thiazolidinones and related analogues as efficient antitrypanosomal agents","volume":"130","author":"Kolarik","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119382_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejmech.2016.07.060","article-title":"Structure-guided discovery of Thiazolidine-2,4-Dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors","volume":"123","author":"Leite","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119382_bib20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2958.2010.07236.x","article-title":"Trypanosoma Brucei pteridine reductase 1 is essential for survival in vitro and for virulence in mice","volume":"77","author":"Sienkiewicz","year":"2010","journal-title":"Mol. Microbiol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119382_bib21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/cmdc.201500301","article-title":"Development of small-molecule Trypanosoma Brucei N-Myristoyltransferase inhibitors: discovery and optimisation of a novel binding mode","volume":"10","author":"Spinks","year":"2015","journal-title":"ChemMedChem"},{"issue":"24","key":"10.1016\/j.ejmech.2026.119382_bib22","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/jm301518v","article-title":"Structural investigation of anti-trypanosoma Cruzi 2-Iminothiazolidin-4-Ones allows the identification of agents with efficacy in infected mice","volume":"55","author":"Moreira","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119382_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cmdc.201300354","article-title":"Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-trypanosoma cruzi activity","volume":"9","author":"Moreira","year":"2014","journal-title":"ChemMedChem"},{"issue":"15","key":"10.1016\/j.ejmech.2026.119382_bib24","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/acs.orglett.1c01894","article-title":"Enantioselective synthesis of chiral substituted 2,4-Diketoimidazolidines and 2,5-Diketopiperazines via asymmetric hydrogenation","volume":"23","author":"Xiao","year":"2021","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.119382_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115611","article-title":"2,6-Disubstituted 7-(Naphthalen-2-Ylmethyl)-7H-Purines as a new class of potent antitubercular agents inhibiting DprE1","volume":"258","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119382_bib26","unstructured":"Https:\/\/Www.Evotec.Com\/Solutions\/Drug-Discovery-Preclinical-Development\/Cyprotex-Adme-Tox-Solutions\/Adme-Pk\/Drug-Metabolism\/Microsomal-Stability."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:54:32Z","timestamp":1793966072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":26,"alternative-id":["S0223523426008275"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119382","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the structural requirements of fluorinated benzylidene-thiazolidinediones for selective antitrypanosomal activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119382"}}